MMP10 and Alzheimer disease: Erhardt et al. showed that patients with mixed AD and vascular dementia show the highest value of CSF MMP-10, ptau, and other inflammatory markers, suggesting that vascular pathology may accelerate cognitive decline, possibly as a result of a disrupted blood-brain barrier and neuroinflammation [34].